Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP602837.RAE3oqcifLyipschNGKCWcdlM6AV4iqGG2ox4ludm0ZXg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP602837.RAE3oqcifLyipschNGKCWcdlM6AV4iqGG2ox4ludm0ZXg130_assertion type Assertion NP602837.RAE3oqcifLyipschNGKCWcdlM6AV4iqGG2ox4ludm0ZXg130_head.
- NP602837.RAE3oqcifLyipschNGKCWcdlM6AV4iqGG2ox4ludm0ZXg130_assertion description "[Osteoprotegerin (OPG) is a potent inhibitor of osteoclast differentiation and activation, but its use as therapeutic agent in cancer-associated osteolysis remains controversial due to its ability to bind and inhibit the apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on tumor cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602837.RAE3oqcifLyipschNGKCWcdlM6AV4iqGG2ox4ludm0ZXg130_provenance.
- NP602837.RAE3oqcifLyipschNGKCWcdlM6AV4iqGG2ox4ludm0ZXg130_assertion evidence source_evidence_literature NP602837.RAE3oqcifLyipschNGKCWcdlM6AV4iqGG2ox4ludm0ZXg130_provenance.
- NP602837.RAE3oqcifLyipschNGKCWcdlM6AV4iqGG2ox4ludm0ZXg130_assertion SIO_000772 19147566 NP602837.RAE3oqcifLyipschNGKCWcdlM6AV4iqGG2ox4ludm0ZXg130_provenance.
- NP602837.RAE3oqcifLyipschNGKCWcdlM6AV4iqGG2ox4ludm0ZXg130_assertion wasDerivedFrom befree-20150227 NP602837.RAE3oqcifLyipschNGKCWcdlM6AV4iqGG2ox4ludm0ZXg130_provenance.
- NP602837.RAE3oqcifLyipschNGKCWcdlM6AV4iqGG2ox4ludm0ZXg130_assertion wasGeneratedBy ECO_0000203 NP602837.RAE3oqcifLyipschNGKCWcdlM6AV4iqGG2ox4ludm0ZXg130_provenance.